Imagine a World …


By Julie Gregory, Chief Health Liaison for Apollo Health

Where healthcare decisions were driven by patient outcomes, not pharmaceutical profits.

In such a world, we wouldn’t cling to Alzheimer’s drugs that, at best, offer marginal benefits, and at worst, may accelerate progression. Oral cholinesterase inhibitors like Aricept and NMDA antagonists like Namenda are widely prescribed despite their inability to stop the disease’s progression, and despite evidence that they may hasten decline.[1]

And yet, these are considered the gold standard.

The newer anti-amyloid infusion drugs — Leqembi and Kisunla — promise more but deliver little for most. For those with the ApoE4 allele (the very population most at risk), these treatments can worsen cognition and cause brain swelling or bleeding that can be fatal.[2]

None of these drugs reverse Alzheimer’s. None offer long-term relief. Yet they’re enthusiastically endorsed by mainstream medicine and generously covered by Medicare, ranging from $2,000 per year for generics to over $26,500 annually for infusions, not including the ongoing costs of MRIs, monitoring, and specialist visits.

It’s time to reimagine what care should look like — starting with putting patients, not profits, at the center.

Now Imagine This World …

A world where your family doctor doesn’t wait for dementia to set in — but takes action early. Where clinically proven ReCODE-style prevention is standard care, and insurance-covered lab panels are run twice a year to catch the root causes of cognitive decline before symptoms appear — causes like insulin resistance, HSV-1, sleep apnea, nutrient deficiencies, and more.

In this world, your doctor tracks key biomarkers like homocysteine and tweaks your treatment to keep your brain sharp. They understand that chronic infections, tick-borne illnesses, and mold toxins can silently erode cognition, and they have the tools to treat them. Safe, toxin-free housing would be readily available during mold remediation — not a luxury, but a basic human right.

Here, Alzheimer’s patients are treated with the same urgency, dignity, and resources as those with cancer. Precision medicine would be the norm, combining stem cells, gene therapy, detox protocols, and other advanced tools with the power of diet and lifestyle. Patients would be supported by a team that teaches the fundamentals: nutrient-rich food, movement, restorative sleep, stress management, brain training, and gentle detoxification. Luxuries like clean air, clean food, and water would be available to all.

And clinically proven nutrients like omega-3s, curcumin, B vitamins, and vitamin D with K2? They wouldn’t be optional wellness add-ons. They’d be recommended by doctors and covered by insurance — just like any other medication.

Think it’s impossible? Think again. Tackling the root causes of chronic diseases that contribute to Alzheimer’s, like obesity, diabetes, and cardiovascular disease, could save our healthcare system billions and give people back years of vibrant, productive life. And this isn’t hype — it’s a conservative estimate. Type 2 diabetes alone drains around $400 billion a year from the U.S. economy — and it’s a condition the ReCODE Protocol routinely prevents and reverses. Imagine the impact of scaling our approach for all of these chronic diseases to protect cognition and overall health.

We don’t lack the science. We lack the will to shift the paradigm. The tools to prevent and even reverse cognitive decline exist today, but they remain sidelined in favor of blockbuster drugs and short-term thinking. It’s time to stop asking what’s profitable and start asking what’s possible. A future where Alzheimer’s is no longer a life sentence is within reach. We just have to choose it.   

---

[1]https://pmc.ncbi.nlm.nih.gov/articles/PMC6324361/#!po=79.6296
[2]https://advances.umw.edu.pl/en/article/2023/32/9/943/